A Biopharma Acquisition: Axtria SalesIQ™ For End-To-End Commercial Operations Consolidation And Optimization

Mergers and acquisitions occur for various business reasons. Consolidation and integration of the entities across systems, functions, processes, and operations are of strategic importance and critical success factors in ensuring the desired outcomes in long term. If not managed well, it can often lead to complicated aftermath. For sales operations teams in life sciences companies, the transition towards supporting the expanded end-to-end (E2E) commercial model needs to be one with minimal impact on the field personnel.

Read this case study to know more about how Axtria’s state-of-the-art commercial planning and operations cloud product suite, Axtria SalesIQ™, supported the expanded commercial operations for a Top 10 biopharma company that recently acquired another pharma company to empower the field force, home office (HO), and business leaders and transition to a new stable state seamlessly while minimizing the disruption.

Highlights of the solution were:

Enhanced user experience across various reports, enabling all required information/performance indicators in one place.

A COVID-19 sensitive and effective IC program and contest designs.

A proprietary algorithm for enhanced target reaches across multiple scenarios.

Enhanced HO and field collaboration with an “always-on” platform.

This global IC solution helped the client achieve pay-out accuracy, field force adherence, faster product launches, and smooth data hand-offs for downstream processes.

Contact us at insights@axtria.com with any questions